| Endocrine system | |||||
|---|---|---|---|---|---|
| Endocrine system / Adrenocortical function testing | |||||
| tetracosactide | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Synacthen (Atnahs Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Suspension for injection | |||||
| Synacthen Depot (Atnahs Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Assessment of pituitary function | |||||
| gonadorelin | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Gonadotrophin replacement therapy | |||||
| choriogonadotropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Ovitrelle (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| follitropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Bemfola (Gedeon Richter (UK) Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Gonal-f (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Ovaleap (Theramex HQ UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for solution for injection | |||||
| Gonal-f (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| lutropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for solution for injection | |||||
| Luveris (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Growth hormone disorders | |||||
| pegvisomant | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for solution for injection | |||||
| Somavert (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| somatropin | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA64 |
|||
| Solution for injection | |||||
| Norditropin FlexPro (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| Omnitrope SurePal (Sandoz Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| Saizen (Merck Serono Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| Powder and solvent for solution for injection | |||||
| Zomacton (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Acromegaly | |||||
| octreotide | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Sandostatin (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Diabetes mellitus | |||||
| acarbose | FORMULARY PRODUCT | ||||
| alogliptin | FORMULARY PRODUCT | ||||
| biphasic insulin aspart | FORMULARY PRODUCT | ||||
| Suspension for injection | |||||
| NovoMix 30 FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoMix 30 Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| biphasic insulin lispro | FORMULARY PRODUCT | ||||
| Suspension for injection | |||||
| Humalog Mix25 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humalog Mix25 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humalog Mix50 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humalog Mix50 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| biphasic isophane insulin | FORMULARY PRODUCT | ||||
| Suspension for injection | |||||
| Humulin M3 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humulin M3 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Hypurin Porcine 30/70 Mix (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
| canagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA390 NICE TA315 |
|||
| dapagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA288 NICE TA390 NICE TA418 NICE TA679 NICE TA902 NICE TA775 |
|||
| dulaglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Solution for injection | |||||
| Trulicity (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| empagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA390 NICE TA336 NICE TA773 NICE TA929 NICE TA942 |
|||
| ertugliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA572 NICE TA583 |
|||
| exenatide | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| gliclazide | FORMULARY PRODUCT | ||||
| Modified-release tablet | |||||
| Gliclazide (Non-proprietary) | FORMULARY PRODUCT | ||||
| Diamicron MR (Servier Laboratories Ltd) | NON-FORMULARY | ||||
| Edicil MR (Teva UK Ltd) | NON-FORMULARY | ||||
| Ziclaseg (Lupin Healthcare (UK) Ltd) | NON-FORMULARY | ||||
| glimepiride | FORMULARY PRODUCT | ||||
| glipizide | NON-FORMULARY | ||||
| insulin | FORMULARY PRODUCT |
NICE TA151 NICE TA943 |
|||
| Solution for injection | |||||
| Insulin (Non-proprietary) | FORMULARY PRODUCT | ||||
| Actrapid (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Humulin S (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Hypurin Porcine Neutral (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
| insulin aspart | FORMULARY PRODUCT |
NICE TA151 |
|||
| Solution for injection | |||||
| Fiasp (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Fiasp FlexTouch (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Fiasp Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoRapid (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoRapid FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoRapid FlexTouch (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoRapid Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| NovoRapid PumpCart (Novo Nordisk Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| insulin degludec | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Solution for injection | |||||
| Tresiba FlexTouch (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Tresiba Penfill (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| insulin detemir | FORMULARY PRODUCT | ||||
| Solution for injection | |||||
| Levemir FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Levemir Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| insulin glargine | FORMULARY PRODUCT | ||||
| Solution for injection | |||||
| Abasaglar (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Abasaglar KwikPen (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Lantus (Sanofi) | FORMULARY PRODUCT | ||||
| insulin glulisine | FORMULARY PRODUCT |
NICE TA151 |
|||
| Solution for injection | |||||
| Apidra (Sanofi) | FORMULARY PRODUCT | ||||
| Apidra SoloStar (Sanofi) | FORMULARY PRODUCT | ||||
| insulin lispro | FORMULARY PRODUCT |
NICE TA151 |
|||
| Solution for injection | |||||
| Humalog (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humalog KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| isophane insulin | FORMULARY PRODUCT | ||||
| Suspension for injection | |||||
| Humulin I (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Humulin I KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Hypurin Porcine Isophane (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
| Insulatard (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Insulatard Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| linagliptin | FORMULARY PRODUCT | ||||
| liraglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA664 |
|||
| Solution for injection | |||||
| Saxenda (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Victoza (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| lixisenatide | NON-FORMULARY | ||||
| metformin hydrochloride | FORMULARY PRODUCT | ||||
| Modified-release tablet | |||||
| Metformin hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
| Glucient SR (Consilient Health Ltd) | NON-FORMULARY | ||||
| Glucophage SR (Merck Serono Ltd) | NON-FORMULARY | ||||
| Meijumet (Medreich Plc) | NON-FORMULARY | ||||
| Metabet SR (Morningside Healthcare Ltd) | NON-FORMULARY | ||||
| Sukkarto SR (Morningside Healthcare Ltd) | NON-FORMULARY | ||||
| Oral solution | |||||
| Metformin hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
| pioglitazone | FORMULARY PRODUCT | ||||
| repaglinide | FORMULARY PRODUCT | ||||
| saxagliptin | NON-FORMULARY | ||||
| semaglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA875 |
|||
| sitagliptin | FORMULARY PRODUCT | ||||
| sitagliptin with metformin | NON-FORMULARY | ||||
| tolbutamide | FORMULARY PRODUCT | ||||
| vildagliptin | FORMULARY PRODUCT | ||||
| vildagliptin with metformin | NON-FORMULARY | ||||
| Endocrine system / Diabetic nephropathy | |||||
| irbesartan | FORMULARY PRODUCT | ||||
| Endocrine system / Diabetic neuropathy | |||||
| capsaicin | HOSPITAL ONLY PRESCRIBING | ||||
| carbamazepine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| duloxetine | FORMULARY PRODUCT | ||||
| Gastro-resistant capsule | |||||
| Duloxetine (Non-proprietary) | FORMULARY PRODUCT | ||||
| Cymbalta (Eli Lilly and Company Ltd) | NON-FORMULARY | ||||
| Yentreve (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
| Endocrine system / Hypoglycaemia | |||||
| glucagon | FORMULARY PRODUCT | ||||
| Powder and solvent for solution for injection | |||||
| GlucaGen Hypokit (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Endocrine system / Chronic hypoglycaemia | |||||
| diazoxide | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Corticosteroid responsive conditions | |||||
| betamethasone | FORMULARY PRODUCT | ||||
| Solution for injection | |||||
| Betamethasone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| deflazacort | NON-FORMULARY | ||||
| dexamethasone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA229 NICE TA824 NICE TA460 |
|||
| Oral solution | |||||
| Dexamethasone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Solution for injection | |||||
| Dexamethasone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| fludrocortisone acetate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| hydrocortisone | FORMULARY PRODUCT | ||||
| Solution for injection | |||||
| Hydrocortisone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Powder for solution for injection | |||||
| Solu-Cortef (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for solution for injection | |||||
| Solu-Cortef (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| methylprednisolone | NON-FORMULARY | ||||
| Powder and solvent for solution for injection | |||||
| Solu-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Suspension for injection | |||||
| Depo-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| prednisolone | FORMULARY PRODUCT | ||||
| Gastro-resistant tablet | |||||
| Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
| Dilacort (Crescent Pharma Ltd) | NON-FORMULARY | ||||
| Oral solution | |||||
| Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
| Suppository | |||||
| Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
| triamcinolone acetonide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Suspension for injection | |||||
| Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | NON-FORMULARY | ||||
| Endocrine system / Cushing's syndrome and disease | |||||
| metyrapone | HOSPITAL ONLY PRESCRIBING | ||||
| pasireotide | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Signifor (Recordati Rare Diseases UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for suspension for injection | |||||
| Signifor (Recordati Rare Diseases UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Female sex hormone responsive conditions | |||||
| conjugated oestrogens with medroxyprogesterone | |||||
| Modified-release tablet | |||||
| Premique (Pfizer Ltd) | FORMULARY PRODUCT | ||||
| estradiol | FORMULARY PRODUCT | ||||
| Transdermal patch | |||||
| Estraderm MX (Norgine Pharmaceuticals Ltd) | NON-FORMULARY | ||||
| Estradot (Sandoz Ltd) | NON-FORMULARY | ||||
| Evorel (Theramex HQ UK Ltd) | FORMULARY PRODUCT | ||||
| FemSeven (Theramex HQ UK Ltd) | NON-FORMULARY | ||||
| Progynova TS (Bayer Plc) | NON-FORMULARY | ||||
| estradiol with dydrogesterone | |||||
| Form unstated | |||||
| Femoston 2/10 (Exeltis UK Ltd) | NON-FORMULARY | ||||
| estradiol with levonorgestrel | |||||
| Transdermal patch | |||||
| FemSeven Conti (Theramex HQ UK Ltd) | NON-FORMULARY | ||||
| estradiol with norethisterone | FORMULARY PRODUCT | ||||
| Form unstated | |||||
| Elleste Duet (Exeltis UK Ltd) | FORMULARY PRODUCT | ||||
| Novofem (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
| Trisequens (Novo Nordisk Ltd) | NON-FORMULARY | ||||
| ethinylestradiol | FORMULARY PRODUCT | ||||
| medroxyprogesterone acetate | FORMULARY PRODUCT | ||||
| norethisterone | FORMULARY PRODUCT | ||||
| progesterone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Solution for injection | |||||
| Progesterone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Lubion (IBSA Pharma Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Vaginal gel | |||||
| Crinone (Merck Serono Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| raloxifene hydrochloride | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA160 NICE TA161 |
|||
| tibolone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Endocrine system / Anti-oestrogens | |||||
| clomifene citrate | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Male sex hormone antagonism | |||||
| cyproterone acetate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Endocrine system / Dopamine responsive conditions | |||||
| bromocriptine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| cabergoline | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| quinagolide | NON-FORMULARY | ||||
| Form unstated | |||||
| Quinagolide (Non-proprietary) | NON-FORMULARY | ||||
| Endocrine system / Bone metabolism disorders | |||||
| alendronic acid | FORMULARY PRODUCT |
NICE TA464 |
|||
| Oral solution | |||||
| Alendronic acid (Non-proprietary) | NON-FORMULARY | ||||
| alendronic acid with colecalciferol | NON-FORMULARY | ||||
| calcitonin (salmon) | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| calcitriol | NON-FORMULARY | ||||
| Oral solution | |||||
| Calcitriol (Non-proprietary) | NON-FORMULARY | ||||
| denosumab | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA204 NICE TA265 |
|||
| Solution for injection | |||||
| Prolia (Amgen Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| Xgeva (Amgen Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| ibandronic acid | NON-FORMULARY |
NICE TA464 |
|||
| Solution for injection | |||||
| Ibandronic acid (Non-proprietary) | NON-FORMULARY | ||||
| Bonviva (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
| Solution for infusion | |||||
| Ibandronic acid (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Bondronat (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
| pamidronate disodium | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for infusion | |||||
| Pamidronate disodium (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| raloxifene hydrochloride | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA160 NICE TA161 |
|||
| risedronate sodium | FORMULARY PRODUCT |
NICE TA464 |
|||
| risedronate with calcium carbonate and colecalciferol | NON-FORMULARY | ||||
| sodium clodronate | HOSPITAL ONLY PRESCRIBING | ||||
| teriparatide | HOSPITAL ONLY PRESCRIBING |
NICE TA161 |
|||
| Solution for injection | |||||
| Forsteo (Eli Lilly and Company Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| zoledronic acid | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA464 |
|||
| Solution for infusion | |||||
| Zoledronic acid (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Zometa (Phoenix Labs Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Diabetes insipidus | |||||
| chlortalidone | FORMULARY PRODUCT | ||||
| desmopressin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Oral lyophilisate | |||||
| DDAVP Melt (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| DesmoMelt (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
| Noqdirna (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Solution for injection | |||||
| DDAVP (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Octim (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| Spray | |||||
| Desmopressin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Desmospray (Imported (Germany)) | NON-FORMULARY | ||||
| vasopressin | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Vasopressin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Syndrome of inappropriate antidiuretic hormone secretion | |||||
| tolvaptan | HOSPITAL ONLY PRESCRIBING |
NICE TA358 |
|||
| Endocrine system / Thyroid disorders | |||||
| thyrotropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
| Powder for solution for injection | |||||
| Thyrogen (Sanofi) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Hyperthyroidism | |||||
| carbimazole | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| iodide with iodine | HOSPITAL ONLY PRESCRIBING | ||||
| metoprolol tartrate | FORMULARY PRODUCT | ||||
| Solution for injection | |||||
| Betaloc (Recordati Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| nadolol | NON-FORMULARY | ||||
| propranolol hydrochloride | FORMULARY PRODUCT | ||||
| Modified-release capsule | |||||
| Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | NON-FORMULARY | ||||
| Beta-Prograne (Accord-UK Ltd) | NON-FORMULARY | ||||
| Half Beta-Prograne (Accord-UK Ltd) | NON-FORMULARY | ||||
| Oral solution | |||||
| Propranolol hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
| propylthiouracil | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Endocrine system / Hypothyroidism | |||||
| levothyroxine sodium | FORMULARY PRODUCT | ||||
| Oral solution | |||||
| Levothyroxine sodium (Non-proprietary) | FORMULARY PRODUCT | ||||
| liothyronine sodium | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Powder for solution for injection | |||||
| Liothyronine sodium (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Gonadotrophin responsive conditions | |||||
| buserelin | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Suprefact (Neon Healthcare Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| cetrorelix | HOSPITAL ONLY PRESCRIBING | ||||
| Powder and solvent for solution for injection | |||||
| Cetrotide (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| ganirelix | HOSPITAL ONLY PRESCRIBING | ||||
| Solution for injection | |||||
| Fyremadel (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| goserelin | HOSPITAL ONLY PRESCRIBING | ||||
| leuprorelin acetate | HOSPITAL ONLY PRESCRIBING | ||||
| nafarelin | HOSPITAL ONLY PRESCRIBING | ||||
| Spray | |||||
| Synarel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
| relugolix with estradiol and norethisterone acetate | HOSPITAL ONLY PRESCRIBING |
NICE TA832 |
|||
| triptorelin | HOSPITAL ONLY PRESCRIBING | ||||
| Endocrine system / Breast pain (mastalgia) | |||||
| tamoxifen | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | NON-FORMULARY | ||||